Recommendations for Management of the Trastuzumab (Herceptin) among Iranian Breast Cancer Patients, A Policy Brief

Recommendations for Management of the Trastuzumab (Herceptin) among Iranian Breast Cancer Patients, A Policy Brief

Background: Allocation of the new (expensive) drugs for difficult refractory diseases and financial protection of the patients is an important challenge in the national health systems worldwide especially in developing countries.  Trastuzumab (Herceptin) as one of the effective but expensive drugs,...

Full description

Bibliographic Details
Main Authors: Mohammad Reza Rouhollahi, Samad Mohammd Nejad, Iraj Harirchi, Behrouz Zarei, Gelavizh Keshtmand, Sanambar Sadighi, Saeid Amanpour, Afshin Abdirad, Parviz Kokhaei, Mehdi Aghili, Farnaz Amoozegar-Hashemi, Mojtaba Vandrajabpour, Kazem Zendehdel
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2014-04-01
Series:Basic & Clinical Cancer Research
Subjects:
Trastuzumab
Breast Cancer
Iran
management
New High-Cost Cancer Drugs (NHCCD)
Online Access:https://bccr.tums.ac.ir/index.php/bccrj/article/view/133

Internet

https://bccr.tums.ac.ir/index.php/bccrj/article/view/133

Similar Items